Practical Guide to Ablation for Epicardial Ventricular Tachycardia: When to Get Access, How to Deal with Anticoagulation and How to Prevent Complications

Ventricular tachycardia (VT) is one of the most challenging medical conditions faced by cardiac patients and physicians treating them. Antiarrhythmic medications have limited effectiveness and are frequently poorly tolerated.1–4 Catheter ablation is increasingly used to treat patients successfully.1,5–7 Most VTs can be ablated endocardially but some require epicardial mapping and ablation.

Sex Differences in Utilisation and Response to Implantable Device Therapy

Implantable cardiac devices such as implantable cardioverter- defibrillators (ICDs) and cardiac resynchronisation therapy (CRT) devices lead to improved survival and better clinical outcomes in appropriately selected patients with heart failure (HF) with a reduced ejection fraction (EF). Although there are significant sex differences in the aetiology, pathophysiology and clinical course of HF, clinical practice guidelines for cardiac device therapy are not sex-specific and are based on clinical trials where the majority of patients enrolled were men.

Reprocessing Cardiology Devices - Reviewing 15 Years of Experience in Germany

The recent acquisitions of two leading American reprocessing businesses by leading medical devices manufacturers have relaunched the debate around the reprocessing of medical devices. In 2009, Stryker acquired Ascent and, more recently, Johnson & Johnson acquired SterilMed. This represents a major shift in the strategy of large medical devices companies. In the past, they were very critical of the concept of reprocessing medical devices and, through various organisations (e.g., Eucomed in Europe), attempted to persuade regulators that it was unsafe.